Samantha Semenkow
Stock Analyst at Citigroup
(2.14)
# 2,917
Out of 5,133 analysts
67
Total ratings
41.82%
Success rate
-2.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Buy | $1,124 → $1,091 | $810.51 | +34.61% | 8 | Jan 8, 2026 | |
| FOLD Amicus Therapeutics | Downgrades: Neutral | $17 → $15 | $14.32 | +1.26% | 2 | Dec 22, 2025 | |
| SYRE Spyre Therapeutics | Initiates: Buy | $64 | $31.53 | +102.98% | 1 | Dec 17, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $16 → $30 | $14.22 | +110.97% | 2 | Dec 9, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $60 → $100 | $77.92 | +28.34% | 2 | Dec 9, 2025 | |
| NKTR Nektar Therapeutics | Initiates: Buy | $102 | $36.58 | +178.84% | 1 | Nov 26, 2025 | |
| AGIO Agios Pharmaceuticals | Initiates: Buy | $38 | $27.80 | +36.69% | 1 | Nov 26, 2025 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Buy | $136 | $107.80 | +26.16% | 1 | Nov 25, 2025 | |
| BHVN Biohaven | Maintains: Buy | $28 → $14 | $10.97 | +27.62% | 2 | Nov 13, 2025 | |
| PRME Prime Medicine | Maintains: Neutral | $5 → $4.25 | $4.16 | +2.16% | 5 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $26 | $23.44 | +10.92% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $33 | $22.35 | +47.65% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $20.69 | -27.50% | 5 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $5 | $17.10 | -70.76% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $10 | $2.15 | +365.12% | 4 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.64 | +143.90% | 3 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.02 | +198.51% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $4.70 | +219.15% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $11.76 | +580.27% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $3.33 | +320.42% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $2.09 | +617.70% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $26.18 | +90.99% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $34.55 | +62.08% | 3 | Aug 9, 2023 |
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $1,124 → $1,091
Current: $810.51
Upside: +34.61%
Amicus Therapeutics
Dec 22, 2025
Downgrades: Neutral
Price Target: $17 → $15
Current: $14.32
Upside: +1.26%
Spyre Therapeutics
Dec 17, 2025
Initiates: Buy
Price Target: $64
Current: $31.53
Upside: +102.98%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $16 → $30
Current: $14.22
Upside: +110.97%
Structure Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $60 → $100
Current: $77.92
Upside: +28.34%
Nektar Therapeutics
Nov 26, 2025
Initiates: Buy
Price Target: $102
Current: $36.58
Upside: +178.84%
Agios Pharmaceuticals
Nov 26, 2025
Initiates: Buy
Price Target: $38
Current: $27.80
Upside: +36.69%
Rhythm Pharmaceuticals
Nov 25, 2025
Initiates: Buy
Price Target: $136
Current: $107.80
Upside: +26.16%
Biohaven
Nov 13, 2025
Maintains: Buy
Price Target: $28 → $14
Current: $10.97
Upside: +27.62%
Prime Medicine
Nov 11, 2025
Maintains: Neutral
Price Target: $5 → $4.25
Current: $4.16
Upside: +2.16%
Nov 11, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $23.44
Upside: +10.92%
Nov 7, 2025
Maintains: Buy
Price Target: $31 → $33
Current: $22.35
Upside: +47.65%
Oct 29, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $20.69
Upside: -27.50%
Oct 29, 2025
Downgrades: Sell
Price Target: $5
Current: $17.10
Upside: -70.76%
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.15
Upside: +365.12%
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.64
Upside: +143.90%
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.02
Upside: +198.51%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $4.70
Upside: +219.15%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $11.76
Upside: +580.27%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $3.33
Upside: +320.42%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $2.09
Upside: +617.70%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $26.18
Upside: +90.99%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $34.55
Upside: +62.08%